Showing results (321-330 of 504) with videos related to
Sort By:
Pageof 51
Blood|October 9, 1998
8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosineR G Halgren, A E Traynor, S Pillay, et al.Archives of Dermatology|April 1, 1986
Histiocytosis X. Flow cytometric DNA-content and immunohistochemical and ultrastructural analysisN S Goldberg, K Bauer, S T Rosen, et al.Cancer Investigation|January 1, 1990
Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) studyJ N Winter, P S Ritch, S T Rosen, et al.Blood|May 1, 1997
Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndromeM Thangavelu, W G Finn, K K Yelavarthi, et al.The American Journal of Pathology|May 1, 1990
Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastomaS L Cohn, A W Rademaker, H R Salwen, et al.Hybridoma|January 1, 1985
Radioimmunoimaging of human small cell lung carcinoma with I-131 tumor specific monoclonal antibodyA M Zimmer, S T Rosen, S M Spies, et al.Nano Letters|November 29, 2023
Universal Conductance Fluctuations in a MnBi2Te4 Thin FilmMolly P Andersen, Evgeny Mikheev, Ilan T Rosen, et al.Nuclear Receptor Signaling|December 31, 2015
Identification of potential glucocorticoid receptor therapeutic targets in multiple myelomaAlexandra L Thomas, Cristian Coarfa, Jun Qian, et al.Molecular Cancer Therapeutics|August 8, 2006
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell linesMujahid A Rizvi, Kulsoom Ghias, Katharine M Davies, et al.Current Hematologic Malignancy Reports|May 22, 2020
Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive ReviewCosimo Di Raimondo, Vishwas Parekh, Joo Y Song, et al.Pageof 51